The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma
Authors
Keywords
Liver transplantation, Hepatocellular carcinoma, Prognosis, Adjuvant targeted therapy, Predicting
Journal
Hepatobiliary & Pancreatic Diseases International
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-04-26
DOI
10.1016/j.hbpd.2022.04.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria
- (2020) Ani Kardashian et al. HEPATOLOGY
- Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma
- (2019) Ping Sun et al. MEDICINE
- Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population
- (2019) Ka Wing Ma et al. World Journal of Gastrointestinal Oncology
- National Experience on Down‐staging of Hepatocellular Carcinoma before Liver Transplant: Influence of Tumor Burden, AFP , and Wait Time
- (2019) Neil Mehta et al. HEPATOLOGY
- EXPERIENCE WITH EARLY SORAFENIB TREATMENT WITH mTOR INHIBITORS IN HEPATOCELLULAR CARCINOMA RECURRING AFTER LIVER TRANSPLANTATION
- (2019) Federica Invernizzi et al. TRANSPLANTATION
- Preoperative Alfa-Fetoprotein and Fibrinogen Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation Regardless of the Milan Criteria: Model Development with External Validation
- (2018) Nan Jiang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
- (2018) Vincenzo Mazzaferro et al. GASTROENTEROLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
- (2018) Cheng-Qian Zhong et al. Cancer Medicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany
- (2018) Zhi Qu et al. LANGENBECKS ARCHIVES OF SURGERY
- New Systemic Treatments in Advanced Hepatocellular Carcinoma
- (2018) Marco Sanduzzi-Zamparelli et al. LIVER TRANSPLANTATION
- Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis
- (2017) Laura Kulik et al. HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
- (2017) Gonzalo Sapisochin et al. Nature Reviews Gastroenterology & Hepatology
- Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant
- (2017) Neil Mehta et al. JAMA Oncology
- The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer
- (2016) Michał Grąt et al. ANNALS OF SURGICAL ONCOLOGY
- Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells
- (2016) Yan Lu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
- (2016) Edward K. Geissler et al. TRANSPLANTATION
- Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update
- (2016) Wen-Ming Cong et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognosis after recurrence of hepatocellular carcinoma in liver transplantation: predictors for successful treatment and survival
- (2015) Shunji Nagai et al. CLINICAL TRANSPLANTATION
- Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients
- (2015) Arno Kornberg et al. DIGESTIVE DISEASES AND SCIENCES
- Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
- (2015) Xiao Xu et al. GUT
- A three-factor preoperative scoring model predicts risk of recurrence after liver resection or transplantation in hepatocellular carcinoma patients with preserved liver function
- (2015) Yang Li et al. Hepatobiliary & Pancreatic Diseases International
- Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
- (2015) Francis Y. Yao et al. HEPATOLOGY
- Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation
- (2015) Shunji Nagai et al. HEPATOLOGY
- A Novel Prognostic Nomogram Accurately Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Analysis of 865 Consecutive Liver Transplant Recipients
- (2015) Vatche G. Agopian et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: A meta-analysis
- (2014) Zhouying Zheng et al. INTERNATIONAL JOURNAL OF CANCER
- Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria
- (2014) Bilal Hameed et al. LIVER TRANSPLANTATION
- The Stratifying Value of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma
- (2014) Jun Chen et al. PLoS One
- Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma
- (2013) Manuel Rodríguez-Perálvarez et al. JOURNAL OF HEPATOLOGY
- How to decide about liver transplantation in patients with hepatocellular carcinoma: Size and number of lesions or response to TACE?
- (2013) Gerd Otto et al. JOURNAL OF HEPATOLOGY
- Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma
- (2012) K. V. Menon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
- (2012) Christophe Duvoux et al. GASTROENTEROLOGY
- Management of HCC
- (2012) Carlos Rodríguez de Lope et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma
- (2011) Shaheed Merani et al. JOURNAL OF HEPATOLOGY
- Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma
- (2011) Thomas Decaens et al. LIVER INTERNATIONAL
- Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation
- (2011) Vivek Kohli et al. TRANSPLANT INTERNATIONAL
- Membrane gamma-glutamyl transferase activity promotes iron-dependent oxidative DNA damage in melanoma cells
- (2009) Alessandro Corti et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Liver Transplantation for Hepatocellular Carcinoma: Hangzhou Experiences
- (2009) Shu-Sen Zheng et al. TRANSPLANTATION
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
- (2008) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started